Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -61.67%4.34M | 685.63%170.88M | 337.35%62.94M | 52.13%13.23M | 36.85%11.32M | -89.37%21.75M | -92.51%14.39M | -93.63%8.69M | -88.03%8.27M | -35.67%204.71M |
Operating revenue | -61.67%4.34M | 685.63%170.88M | 337.35%62.94M | 52.13%13.23M | 36.85%11.32M | -89.37%21.75M | -92.51%14.39M | -93.63%8.69M | -88.03%8.27M | -35.67%204.71M |
Total operating cost | 4.88%22.81M | 208.65%194.7M | 162.74%101.27M | 80.02%45.69M | 42.03%21.75M | -61.19%63.08M | -73.54%38.54M | -75.21%25.38M | -69.61%15.31M | -29.95%162.54M |
Operating cost | -40.78%5.29M | 441.77%114.75M | 240.60%45.35M | 41.71%11.3M | 24.55%8.94M | -83.49%21.18M | -88.91%13.31M | -90.61%7.98M | -83.25%7.18M | -35.93%128.3M |
Operating tax surcharges | 8.62%766.78K | 841.19%3.75M | 3,527.80%2.4M | 4,615.43%1.72M | 3,305.75%705.93K | 191.54%398.74K | -42.13%66.12K | -54.00%36.54K | 26.83%20.73K | -85.11%136.77K |
Operating expense | 98.07%2.13M | 112.82%7.88M | 162.79%4.51M | 133.84%2.52M | 148.46%1.07M | 176.46%3.7M | 126.92%1.71M | 134.98%1.08M | 95.59%431.91K | 14.22%1.34M |
Administration expense | 6.75%7.13M | 59.66%34.1M | 83.35%24.96M | 102.18%16.41M | 116.24%6.68M | 45.01%21.36M | 16.45%13.61M | -10.29%8.11M | -9.07%3.09M | 57.30%14.73M |
Financial expense | 44.47%-2.5M | 26.13%-13.08M | 12.32%-10.46M | -31.08%-7.78M | -155.92%-4.5M | -251.98%-17.7M | -220.80%-11.93M | -196.00%-5.94M | -886.81%-1.76M | -1,473.19%-5.03M |
-Interest expense (Financial expense) | 336.80%101.87K | 157.13%320.68K | 224.77%318.98K | 227.61%224.65K | -34.90%23.32K | 278.40%124.72K | 392.16%98.22K | 312.99%68.57K | 260.42%35.82K | 55.18%32.96K |
-Interest Income (Financial expense) | 42.70%-2.61M | 23.84%-13.62M | 9.49%-10.93M | -34.57%-8.12M | -152.52%-4.56M | -241.66%-17.89M | -209.71%-12.07M | -178.25%-6.03M | -563.79%-1.81M | -708.83%-5.24M |
Research and development | 12.89%10M | 38.52%47.3M | 58.59%34.52M | 52.49%21.51M | 39.34%8.86M | 48.02%34.14M | 29.65%21.76M | 43.81%14.11M | 55.28%6.35M | 11.68%23.07M |
Credit Impairment Loss | 123.87%2.73M | 292.03%23.73M | -55.34%-6.04M | -1,206.13%-5.58M | -9,158.09%-11.46M | 3.82%-12.36M | 62.90%-3.89M | 112.97%504.8K | 104.51%126.5K | -275.59%-12.85M |
Asset Impairment Loss | -17,511.87%-1.02M | -54,574.86%-10.33M | ---3.19M | ---2.51M | ---5.78K | ---18.89K | ---- | ---- | ---- | ---- |
Other net revenue | ||||||||||
Fair value change income | 67.12%1.67M | -50.80%4.54M | -80.01%3.27M | -87.77%2M | -73.42%1M | -22.69%9.22M | 109.36%16.35M | 271.48%16.35M | 607.34%3.76M | --11.92M |
Invest income | -22.55%-772.16K | -2,761.58%-1.5M | -2,032.41%-892.84K | -274.09%-774.59K | -243.19%-630.1K | -100.96%-52.55K | -100.96%-41.87K | -81.26%444.93K | --440.03K | --5.45M |
-Including: Investment income associates | -61.81%-1.02M | -34.81%-1.74M | 21.69%-1M | -5.52%-837.19K | ---630.1K | ---1.29M | ---1.28M | ---793.41K | ---- | ---- |
Asset deal income | ---- | --47.27K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other revenue | 61.04%217.33K | -93.54%966.71K | -98.01%296.61K | -98.75%181.59K | -99.07%134.95K | 5.84%14.97M | -7.78%14.94M | 302.90%14.47M | 171,422.39%14.47M | 1,852.92%14.15M |
Operating profit | 26.89%-15.64M | 78.43%-6.38M | -1,499.75%-44.9M | -359.52%-39.15M | -281.97%-21.39M | -148.60%-29.57M | -95.01%3.21M | -62.78%15.09M | -28.50%11.76M | -27.13%60.84M |
Add:Non operating Income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Less:Non operating expense | --333.74 | 6,469.69%149.86K | 17,233.56%142.39K | --139.12K | ---- | --2.28K | --821.49 | ---- | ---- | --0 |
Total profit | 26.89%-15.64M | 77.92%-6.53M | -1,504.55%-45.04M | -360.44%-39.29M | -281.97%-21.39M | -148.61%-29.57M | -95.01%3.21M | -62.78%15.09M | -28.50%11.76M | -27.13%60.84M |
Less:Income tax cost | 12.68%-3.17M | 48.37%-3.63M | -650.45%-9.59M | -1,115.73%-7.4M | -567.07%-3.63M | -239.49%-7.02M | -116.31%-1.28M | -85.89%729.02K | -64.95%776.75K | -51.66%5.03M |
Net profit | 29.79%-12.47M | 87.12%-2.9M | -890.63%-35.45M | -322.09%-31.88M | -261.80%-17.76M | -140.41%-22.55M | -92.05%4.48M | -59.40%14.36M | -22.82%10.98M | -23.63%55.8M |
Net profit from continuing operation | 29.79%-12.47M | 87.12%-2.9M | -890.63%-35.45M | -322.09%-31.88M | -261.80%-17.76M | -140.41%-22.55M | -92.05%4.48M | -59.40%14.36M | -22.82%10.98M | -23.63%55.8M |
Less:Minority Profit | ---1.96M | --1.63M | ---2.36M | ---1.28M | ---- | ---- | ---- | ---- | ---- | ---- |
Net profit of parent company owners | 40.80%-10.52M | 79.90%-4.53M | -837.95%-33.09M | -313.18%-30.61M | -261.80%-17.76M | -140.41%-22.55M | -92.05%4.48M | -59.40%14.36M | -22.82%10.98M | -23.63%55.8M |
Earning per share | ||||||||||
Basic earning per share | 38.10%-0.13 | 80.77%-0.05 | -880.00%-0.39 | -325.00%-0.36 | -275.00%-0.21 | -138.24%-0.26 | -92.86%0.05 | -65.22%0.16 | -45.45%0.12 | -38.74%0.68 |
Diluted earning per share | 38.10%-0.13 | 80.77%-0.05 | -880.00%-0.39 | -325.00%-0.36 | -275.00%-0.21 | -138.24%-0.26 | -92.86%0.05 | -65.22%0.16 | -45.45%0.12 | -38.74%0.68 |
Other composite income | ||||||||||
Total composite income | 29.79%-12.47M | 87.12%-2.9M | -890.63%-35.45M | -322.09%-31.88M | -261.80%-17.76M | -140.41%-22.55M | -92.05%4.48M | -59.40%14.36M | -22.82%10.98M | -23.63%55.8M |
Total composite income of parent company owners | 40.80%-10.52M | 79.90%-4.53M | -837.95%-33.09M | -313.18%-30.61M | -261.80%-17.76M | -140.41%-22.55M | -92.05%4.48M | -59.40%14.36M | -22.82%10.98M | -23.63%55.8M |
Total composite income of minority owners | ---1.96M | --1.63M | ---2.36M | ---1.28M | ---- | ---- | ---- | ---- | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
Auditor | -- | -- | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.